Background and Purpose: Endothelin peptides are potent vasoconstrictors and thus are seen as potential cause of cerebral vasospasm after subarachnoid hemorrhage (SAH). Earlier reports showed elevated or normal endothelin levels in plasma and cerebrospinal fluid in patients suflering from SAH. The present study was designed to determine whether endothelin is a causal factor in SAH.
S ince the first studies of endothelins in 1988,1 the number of reports concerning these peptides increased rapidly. This so-called "endothelin explosion"' focused on the pathophysiological importance of the endothelins in subarachnoid hemorrhage (SAH). Endothelin-1 and big endothelin are especially potent vasoconstrictors and are able to produce longterm effects on blood vessels.2,3 Thus, these peptides are seen as important causal factors of vasospasm after SAH. An increased plasma endothelin-1 level has been recently demonstrated to be associated with a poor prognosis in acute ischemic stroke. 4 First reports showed especially elevated levels of endothelin-1 in the cerebrospinal fluid (CSF) and plasma of postoperative patients with SAH. [5] [6] [7] However, other reports do not support this hypothesis of plasma endothelin activation in patients after SAH.8 9 Because big endothelin is the active precursor of endothelin-1, it probably gives the best information about activation of the endothelin system.2,3,10 Therefore, we measured big endothelin in plasma and in some cases in CSF during the first 3 weeks after spontaneous SAH.
Subjects and Methods

Patients
Eleven consecutive patients suffering from acute SAH were included in the study. Mean age was 53 years with a range of 37-75 years. There were seven women and four men. SAH was verified by means of cranial computed tomography and/or lumbar puncture in all cases. Time between acute bleeding and admission to the hospital ranged between 1 and 8 days. All patients underwent panangiography with oblique projections. In seven cases, at least one aneurysm was revealed as cause of the bleeding.
Flow velocities in the basal arteries of the circle of Willis were measured by means of transcranial Doppler sonography (Eden Medizin Electronic), and vasospasms were classified according to the criteria of Harders and Gilsbach. No patient showed any sign of cardiac insufficiency, ischemia, or concomitant infections. Blood was drawn from arterial catheters in all patients and immediately transferred to chilled tubes with EDTA. Tubes were precooled at 4°C, and blood samples were transported in ice water, centrifuged at 3,000 rpm for 15 minutes at 40C, and immediately assayed or stored at -70°C until the assay.
Radioimmunoassay
Big endothelin was determined using a radioimmunoassay recognizing the C-terminal peptide.10 This is a part of big endothelin, which is cleaved into C-peptide and endothelin-1 by a protease.1"'0 The radioimmunoassay provides information about both peptides and is highly sensitive in determining activation of the endothelin system.1'10 The assay was performed with a big endothelin kit (Biomedica GmbH, A-1210 Wien, Divischgasse 4). The antibody used in the present radioimmunoassay reacted 82% with big endothelin fragment 22-38 and cross-reacted less than 1% with endothelin-1, endothelin-2, and endothelin-3. The minimum detectable dose was 0.2 fmol/ml, and the range of the Plasma endothelin elevations are not reproducible in SAH and are thus not thought to be a basic parameter in vasospasm pathophysiology. The research into singular vasospasm-causing factors is disappointing, and its history reflects a changing focus on new substances, such as serotonin and prostaglandins. The complex vasospasm after SAH is seen today as a multifactorial development. We support this concept and advise against regarding endothelin as a single main causal factor.
